实验性肺结核病变类型与特点

doi:10.19982/j.issn.1000-6621.20220134

摘要/Abstract

摘要：

实验性肺结核不同于临床肺结核,其病变有自身特点。各种实验动物的肺结核动物模型病变多种多样。由于实验动物种类、品系、毒株、感染剂量、感染途径的差异,病变存在较大差异,相关研究结果也不一致。本文介绍了实验性肺结核的动物模型、发生发展、病变类型、病变程度的评分,以及抗结核药物与疫苗的有效性评价,特别是结核分枝杆菌感染后极早期的血管周围炎、细/小支气管周围炎;还总结了多种实验动物的肺结核病理特点,包括小鼠、豚鼠、羊、非人灵长类等动物;并针对结核病理改变与特点提出了新的分类方法,该分类不仅包括间质纤维化、结核性肺炎、空洞与钙化、结节、坏死,还包括脓肿、肺气肿、肺充血等,同时间质性肺炎(肺间质纤维化)也被纳入肺结核的损伤类型。

关键词: 结核,肺, 动物,实验, 分类法, 病理过程, 模型,动物

Abstract:

Experimental pulmonary tuberculosis is different from clinical pulmonary tuberculosis and its pathological changes have its own characteristics. Pathology tuberculosis from animal models are varied. The differences in laboratory animal species and strain, tuberculosis strain, infection dose and challenge route result in great differences in pathology, and the related research results are inconsistent. This article summarizes experimental pulmonary tuberculosis, including animal model, its occurrence and development, lesion type, scoring of tuberculosis lesion and effectiveness evaluation of anti-tuberculosis drugs and vaccines, especially the perivasculitis/periangitis and peribronchiolitis in very early stage after tuberculosis infection. The pathological characteristics of pulmonary tuberculosis in multiple experimental animals are illustrated, such as mice, guinea pigs, goats and non-human primates. A new classification method is proposed in this article according to the characteristics of the subsequent pathological lesion after tuberculosis infection and these types consist of not only nodules, necrosis, tuberculous pneumonia, cavities and calcification/mineralization, but also lung abscess, emphysema, lung congestion, etc. Interstitial pneumonia (interstitial fibrosis) are also included as the lesion types of experimental pulmonary tuberculosis.

Key words: Tuberculosis,pulmonary, Animals,laboratory, Classification, Pathologic processes, Models,animal

中图分类号:

R521
R365

包容, 高建峰, 饶艳. 实验性肺结核病变类型与特点[J]. 中国防痨杂志, 2022, 44(9): 898-905. doi: 10.19982/j.issn.1000-6621.20220134

Bao Rong, Gao Jianfeng, Rao Yan. Pathological types and characteristics of experimental pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 898-905. doi: 10.19982/j.issn.1000-6621.20220134

图/表 6

图1、2

图4

图5

图6~8

图9

图10~12

参考文献 61

[1]	Irwin SM, Driver E, Lyon E, et al. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Dis Model Mech, 2015, 8(6): 591-602. doi: 10.1242/dmm.019570. doi: 10.1242/dmm.019570 URL
[2]	Kramnik I, Beamer G. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Semin Immunopathol, 2016, 38(2): 221-237. doi: 10.1007/s00281-015-0538-9. doi: 10.1007/s00281-015-0538-9 pmid: 26542392
[3]	Benini J, Ehlers EM, Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J Pathol, 1999, 189(1): 127-137. doi: 10.1002/(SICI)1096-9896(199909)189:13.0.CO;2-S. doi: 10.1002/(SICI)1096-9896(199909)189:13.0.CO;2-S pmid: 10451499
[4]	Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis, 1997, 78(1): 57-66. doi: 10.1016/S0962-8479(97)90016-2. doi: 10.1016/S0962-8479(97)90016-2 URL
[5]	Lin PL, Rodgers M, Smith L, et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun, 2009, 77(10): 4631-4642. doi: 10.1128/IAI.00592-09. doi: 10.1128/IAI.00592-09 URL
[6]	Singh AK, Gupta UD. Animal models of tuberculosis: lesson learnt. Indian J Med Res, 2018, 147(5): 456. doi: 10.4103/ijmr.IJMR_554_18. doi: 10.4103/ijmr.IJMR_554_18 URL
[7]	Gong W, Liang Y, Wu X. Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. Biomed Res Int, 2020, 2020(9):1-21. doi: 10.1155/2020/4263079. doi: 10.1155/2020/4263079
[8]	Fonseca KL, Rodrigues PNS, Olsson IAS, et al. Experimental study of tuberculosis: From animal models to complex cell systems and organoids. PLoS Pathog, 2017, 13(8): e1006421. doi: 10.1371/journal.ppat.1006421. doi: 10.1371/journal.ppat.1006421 URL
[9]	Zhan L, Tang J, Sun M, et al. Animal models for tuberculosis in translational and precision medicine. Front Microbiol, 2017, 8: 717. doi: 10.3389/fmicb.2017.00717. doi: 10.3389/fmicb.2017.00717 URL
[10]	Plumlee CR, Duffy FJ, Gern BH, et al. Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis. Cell Host Microbe, 2021, 29(1): 68-82.e5. doi: 10.1016/j.chom.2020.10.003. doi: 10.1016/j.chom.2020.10.003 URL
[11]	Lu J, Wang C, Zhou Z, et al. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. Clin Dev Immunol, 2011, 2011: 617892. doi: 10.1155/2011/617892. doi: 10.1155/2011/617892
[12]	Seimon TA, Kim MJ, Blumenthal A, et al. Induction of ER stress in macrophages of tuberculosis granulomas. PLoS One, 2010, 5(9): e12772. doi: 10.1371/journal.pone.0012772. doi: 10.1371/journal.pone.0012772 URL
[13]	de Knegt GJ, Marian T, et al. Relapse of tuberculosis versus primary tuberculosis; course, pathogene-sis and therapy in mice. Tuberculosis (Edinb), 2013, 93(2): 213-221. doi: 10.1016/j.tube.2012.11.006. doi: 10.1016/j.tube.2012.11.006 URL
[14]	Orme IM, Basaraba RJ. The formation of the granuloma in tuberculosis infection. Semin Immunol, Academic Press, 2014, 26(6): 601-609. doi: 10.1016/j.smim.2014.09.009. doi: 10.1016/j.smim.2014.09.009
[15]	Sun J, Zhuang Z, Zheng J, et al. Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment. Cell, 2020, 182(3): 734-743. e5. doi: 10.1016/j.cell.2020.06.010. doi: 10.1016/j.cell.2020.06.010 URL
[16]	Singhal A, Aliouat EM, Hervé M, et al. Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infection. PLoS One, 2011, 6(4): e18632. doi: 10.1371/journal.pone.0018632. doi: 10.1371/journal.pone.0018632 URL
[17]	Cáceres N, Tapia G, Ojanguren I, et al. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb), 2009, 89(2): 175-182. doi: 10.1016/j.tube.2008.11.001. doi: 10.1016/j.tube.2008.11.001 URL
[18]	Cardona PJ, Llatjos R, Gordillo S, et al. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol, 2000, 52(2): 156-163. doi: 10.1046/j.1365-3083.2000.00763.x. doi: 10.1046/j.1365-3083.2000.00763.x. pmid: 10931383
[19]	Lin PL, Pawar S, Myers A, et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun, 2006, 74(7): 3790-3803. doi: 10.1128/iai.00064-06. doi: 10.1128/iai.00064-06 URL
[20]	Manabe YC, Kesavan AK, Lopez-Molina J, et al. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis (Edinb), 2008, 88(3): 187-196. doi: 10.1016/j.tube.2007.10.006. doi: 10.1016/j.tube.2007.10.006 URL
[21]	Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis granuloma-the critical battlefield in host immunity and disease. Front Immunol, 2013, 4: 98. doi: 10.3389/fimmu.2013.00098. doi: 10.3389/fimmu.2013.00098 pmid: 23626591
[22]	Russell DG, Cardona PJ, Kim MJ, et al. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol, 2009, 10(9): 943-948. doi: 10.1038/ni.1781. doi: 10.1038/ni.1781 pmid: 19692995
[23]	Russell DG, Barry CE 3rd, Flynn JAL. Tuberculosis: what we don’t know can, and does, hurt us. Science, 2010, 328(5980): 852-856. doi: 10.1126/science.1184784. doi: 10.1126/science.1184784 pmid: 20466922
[24]	Liu X, Da Z, Wang Y, et al. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Vaccine, 2016, 34(11): 1370-1378. doi: 10.1016/j.vaccine.2016.01.049. doi: 10.1016/j.vaccine.2016.01.049 URL
[25]	Cyktor JC, Carruthers B, Kominsky RA, et al. IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection. J Immunol, 2013, 190(6): 2778-2790. doi: 10.4049/jimmunol.1202722. doi: 10.4049/jimmunol.1202722 URL
[26]	Falero-Diaz G, Challacombe S, Banerjee D, et al. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine, 2000, 18(28): 3223-3229. doi: 10.1016/S0264-410X(00)00134-1. doi: 10.1016/S0264-410X(00)00134-1 pmid: 10869767
[27]	Cassidy JP, Bryson DG, Cancela MMG, et al. Lymphocyte subtypes in experimentally induced early-stage bovine tuberculous lesions. J Comp Pathol, 2001, 124(1): 46-51. doi: 10.1053/jcpa.2000.0427. doi: 10.1053/jcpa.2000.0427 pmid: 11428188
[28]	Zhang J, Xian Q, Guo M, et al. Mycobacterium tuberculosis Erdman infection of rhesus macaques of Chinese origin. Tuberculosis (Edinb), 2014, 94(6): 634-643. doi: 10.1016/j.tube.2014.08.005. doi: 10.1016/j.tube.2014.08.005 URL
[29]	Yang E, Gu J, Wang F, et al. Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice. Microb Pathog, 2016, 93: 1-7. doi: 10.1016/j.micpath.2016.01.006. doi: 10.1016/j.micpath.2016.01.006 URL
[30]	Driver ER, Ryan GJ, Hoff DR, et al. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2012, 56(6): 3181-3195. doi: 10.1128/aac.00217-12. doi: 10.1128/AAC.00217-12 pmid: 22470120
[31]	Gonzalez-Juarrero M, Bosco-Lauth A, Podell B, et al. Experimental aerosol Mycobacterium bovis model of infection in goats. Tuberculosis (Edinb), 2013, 93(5): 558-564. doi: 10.1016/j.tube.2013.05.006. doi: 10.1016/j.tube.2013.05.006 URL
[32]	Via LE, Weiner DM, Schimel D, et al. Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect Immun, 2013, 81(8): 2909-2919. doi: 10.1128/IAI.00632-13. doi: 10.1128/IAI.00632-13 URL
[33]	Yang E, Yang R, Guo M, et al. Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses. Emerg Microbes Infect, 2018, 7(1): 1-12. doi: 10.1038/s41426-018-0213-z. doi: 10.1038/s41426-018-0213-z
[34]	Chen CY, Yao S, Huang D, et al. Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog, 2013, 9(8): e1003501. doi: 10.1371/journal.ppat.1003501. doi: 10.1371/journal.ppat.1003501
[35]	Wolschendorf F, Ackart D, Shrestha TB, et al. Copper resis-tance is essential for virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A, 2011, 108(4): 1621-1626. doi: 10.1073/pnas.1009261108. doi: 10.1073/pnas.1009261108 pmid: 21205886
[36]	Helke KL, Mankowski JL, Manabe YC. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinb), 2006, 86(5): 337-348. doi: 10.1016/j.tube.2005.09.001. doi: 10.1016/j.tube.2005.09.001 URL
[37]	Lenaerts A, Barry Ⅲ CE, Dartois V. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev, 2015, 264(1): 288-307. doi: 10.1111/imr.12252. doi: 10.1111/imr.12252 pmid: 25703567
[38]	Arrey F, Löwe D, Kuhlmann S, et al. Humanized mouse model mimicking pathology of human tuberculosis for in vivo evaluation of drug regimens. Front Immunol, 2019, 10: 89. doi: 10.3389/fimmu.2019.00089. doi: 10.3389/fimmu.2019.00089 URL
[39]	Lin PL, Dartois V, Johnston PJ, et al. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc Natl Acad Sci U S A, 2012, 109(35): 14188-14193. doi: 10.1073/pnas.1121497109. doi: 10.1073/pnas.1121497109 URL
[40]	Hunter RL, Jagannath C, Actor JK. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb), 2007, 87(4): 267-278. doi: 10.1016/j.tube.2006.11.003. doi: 10.1016/j.tube.2006.11.003 URL
[41]	Lanoix JP, Lenaerts AJ, Nuermberger EL. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis. Dis Model Mech, 2015, 8(6): 603-610. doi: 10.1242/dmm.019513. doi: 10.1242/dmm.019513 URL
[42]	Gil O, Guirado E, Gordillo S, et al. Intragranulomatous necro-sis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type. Microbes Infect, 2006, 8(3): 628-636. doi: 10.1016/j.micinf.2005.08.014. doi: 10.1016/j.micinf.2005.08.014 URL
[43]	Ravimohan S, Kornfeld H, Weissman D, et al. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev, 2018, 27(147):170077. doi: 10.1183/16000617.0077-2017. doi: 10.1183/16000617.0077-2017
[44]	Dheda, Booth H, Huggett JF, et al. Lung remodeling in pulmonary tuberculosis. J Infect Dis, 2005, 192(7):1201-1210. doi: 10.1086/444545. doi: 10.1086/444545 URL
[45]	Lin PL, Coleman T, Carney JPJ, et al. Radiologic responses in cynomolgus macaques for assessing tuberculosis chemo-therapy regimens. Antimicrob Agents Chemother, 2013, 57(9): 4237-4244. doi: 10.1128/AAC.00277-13. doi: 10.1128/AAC.00277-13 URL
[46]	Flynn JAL, Gideon HP, Mattila JT, et al. Immunology studies in non-human primate models of tuberculosis. Immunol Rev, 2015, 264(1): 60-73. doi: 10.1111/imr.12258. doi: 10.1111/imr.12258 URL
[47]	Sweeney KA, Dao DN, Goldberg MF, et al. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med, 2011, 17(10): 1261-1268. doi: 10.1038/nm.2420. doi: 10.1038/nm.2420 pmid: 21892180
[48]	Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature, 2020, 583(7818): 834-838. doi: 10.1038/nm.2420. doi: 10.1038/nm.2420 URL
[49]	Zhang YN, Li XD, Zhang ZR, et al. A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE 2 using alphavirus replicon particles. Cell Res, 2020, 30(11): 1046-1048. doi: 10.1038/s41422-020-00405-5. doi: 10.1038/s41422-020-00405-5 URL
[50]	Hölscher C, Hölscher A, Rückerl D, et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol, 2005, 174(6): 3534-3544. doi: 10.4049/jimmunol.174.6.3534. doi: 10.4049/jimmunol.174.6.3534 URL
[51]	Zhang J, Guo M, Rao Y, et al. Mycobacterium tuberculosis Erdman infection of cynomolgus macaques of Chinese origin. J Thorac Dis, 2018, 10(6): 3609-3621. doi: 10.21037/jtd.2018.05.189. doi: 10.21037/jtd.2018.05.189 pmid: 30069358
[52]	Tsenova L, Singhal A. Effects of host-directed therapies on the pathology of tuberculosis. J Pathol, 2020, 250(5): 636-646. doi: 10.1002/path.5407. doi: 10.1002/path.5407 URL
[53]	陈保文, 沈小兵, 卢锦标, 等. 治疗性新型结核疫苗保护力评价用动物模型的建立. 中华微生物学和免疫学杂志, 2013, 33(12): 906-910. doi: 10.3760/cma.j.issn.0254-5101.2013.12.004. doi: 10.3760/cma.j.issn.0254-5101.2013.12.004
[54]	Darrah PA, Zeppa JJ, Maiello P, et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature, 2020, 577(7788): 95-102. doi: 10.1038/s41586-019-1817-8. doi: 10.1038/s41586-019-1817-8 URL
[55]	Peña JC, Ho WZ. Monkey models of tuberculosis: lessons learned. Infect Immun, 2015, 83(3): 852-862. doi: 10.1128/IAI.02850-14. doi: 10.1128/IAI.02850-14 URL
[56]	Dharmadhikari AS, Nardell EA. What animal models teach humans about tuberculosis. Am J Respir Cell Mol Biol, 2008, 39(5): 503-508. doi: 10.1165/rcmb.2008-0154TR. doi: 10.1165/rcmb.2008-0154TR URL
[57]	Frantz FG, Rosada RS, Peres-Buzalaf C, et al. Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis. PLoS Negl Trop Dis, 2010, 4(6): e700. doi: 10.1371/journal.pntd.0000700. doi: 10.1371/journal.pntd.0000700 URL
[58]	Wang P, Wang L, Zhang W, et al. Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT 6 fusion protein against persistent tuberculosis infection in mice. Hum Vaccin Immunother, 2014, 10(1): 150-158. doi: 10.4161/hv.26171. doi: 10.4161/hv.26171 URL
[59]	Sharpe S, White A, Gleeson F, et al. Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques. Tuberculosis (Edinb), 2016, 96: 1-12. doi: 10.1016/j.tube.2015.10.004. doi: 10.1016/j.tube.2015.10.004 URL
[60]	Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinb), 2011, 91(6): 497-509. doi: 10.1016/j.tube.2011.03.007. doi: 10.1016/j.tube.2011.03.007 URL
[61]	包容. 实验动物结核病病变程度的评价. 结核病与肺部健康杂志, 2017, 6(3): 204-207. doi: 10.3969/j.issn.2095-3755.2017.03.004. doi: 10.3969/j.issn.2095-3755.2017.03.004